“…Mechanistic studies indicate that ROS induction is a prerequisite for proapoptotic activity and emphasize the importance of the intrinsic (mitochondrial) apoptosis pathway in mediating cell killing (Jing et al, 1999;Hail and Lotan, 2000;Wu et al, 2001;Miller et al, 2002;Simeone et al, 2002;Vuky et al, 2002;Li et al, 2003). These investigations and a number of others document several interesting parallels between how ROS inducers and mda-7/IL-24 kills various tumor cells, including pancreatic tumor cells following ablation of K-ras (Su et al, 2001) or treatment with ARS, HPR or NSC (Delia et al, 1995;Jing et al, 1999;Hail and Lotan, 2000;Wu et al, 2001;Kim et al, 2002;Miller et al, 2002;Simeone et al, 2002;Vuky et al, 2002;Xia et al, 2002;Zou et al, 2002;Lebedeva et al, 2003b;Li et al, 2003). Apoptosis induced by Ad.mda-7 in 'permissive' prostate, melanoma and malignant glioma cells and in 'resistant' pancreatic cancer cells (simultaneously treated with K-ras antisense phosphorothioate oligonucleotides) results in alterations in the ratio of antiapoptotic (such as Bcl-2 and Bcl-x L ) and proapoptotic (including Bax and Bak) proteins, changes in cell cycle resulting in accumulation of cells in the G 2 /M phase and upregulation in expression of the growth arrest and DNA damage inducible (GADD) gene family (Su et al, 2001Lebedeva et al, 2002Lebedeva et al, , 2003aSarkar et al, 2002b).…”